Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada Phase 3 Trials Initiated with Tegoprazan for the Treatment of Erosive Esophagitis and Non-erosive Reflux Disease Sebela Pharmaceuticals® has entered an exclusive partnership with HK inno.N Corporation to license tegoprazan in the United States and Canada. Under the agreement, Braintree Laboratories, a leader… Read more »
Fort Worth, Texas, April 1, 2022. As the Nation’s leading provider of inspection, maintenance, repair and specialized construction services for industrial railroad infrastructure, American Track is proud to announce the acquisition of The Railroad Associates Corp (TRAC) in Boiling Springs, PA. In 2021 DFW Capital Partners acquired American Track and has assisted with an aggressive… Read more »
For Immediate Release March 31, 2022 Teaneck, NJ DFW Capital Partners announced today that Patrick Fairfield has been promoted to the position of Vice President. Based in the firm’s Teaneck, NJ office, Pat joined DFW in 2017 as an Associate. Pat has been actively involved in deal execution, debt financing arrangement and portfolio monitoring for… Read more »
For Immediate Release January 12, 2022 Teaneck, NJ DFW Capital Partners successfully exits its investment in Children’s Dental Management DFW Capital Partners (“DFW”) is pleased to announce that it has completed the sale of its portfolio company, CDHA Holdings, LLC (“Children’s Dental Management”, “CDM” or the “Company”). CDM is the largest pediatric specialist-led dental support… Read more »
BRIDGEWATER, N.J. & ROSWELL, Ga.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) and Saol Therapeutics, a private specialty pharmaceutical company (“Saol”), today announced a definitive agreement under which Amneal will acquire Saol’s Baclofen franchise, including Lioresal® and LYVISPAHTM as well as a pipeline product under development. The acquisition expands Amneal’s commercial institutional and specialty portfolio in neurology while… Read more »
December 6, 2021 Saol Therapeutics Announces FDA Approval of LYVISPAHTM (baclofen) Oral Granules and the Divesture of its Plasma-derived Hyperimmune Portfolio Saol Therapeutics announces the approval of LYVISPAHTM (baclofen) oral granules. The company also announces the strategic transaction to divest the plasma-derived hyperimmune portfolio to Kamada Ltd. for a total value of up to $160M… Read more »
December 14, 2021 DFW Capital Partners (“DFW”), announced today that it has completed a growth investment in Herspiegel Consulting, a leading provider of commercial strategy and implementation consulting for the pharmaceutical and biotechnology industry. Founded in 2007 and headquartered in Yardley, PA, Herspiegel Consulting has advised start-ups to Fortune 100 pharmaceutical clients on commercial projects… Read more »
December 13, 2021 – Teaneck, NJ DFW Capital Partners (“DFW”) is pleased to announce that it has completed the sale of its portfolio company, ReSource Pro Holdings, Inc. (“ReSource Pro” or the “Company”). ReSource Pro is the leader in providing strategic business process management and outsourcing to the insurance industry – focusing on delivering dedicated… Read more »
Fort Worth, Texas, November 30, 2021 – American Track, the Nation’s leading provider of inspection, maintenance, repair and specialized construction services for industrial railroad infrastructure, announced the closing on a recapitalization transaction led by DFW Capital Partners. Operating from nine branch offices in strategically located markets, the Company provides mission critical services for its customers… Read more »
November 02, 2021 – VertexOne, a leading provider of enhanced SaaS solutions to the utility industry, announces the completion of their acquisition of EC Infosystems, the largest provider of Customer Information Systems (CIS), Billing, and Electronic Data Interchange (EDI) to retail energy companies in North America. This acquisition marks another step in VertexOne’s ongoing strategy… Read more »
